Retrospective analysis of image-guided sentinel lympadenectomy in prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032808

Enrollment

Registered

2023-10-06

Start date

2023-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: intraprostatic injection of a magnetic fluorescent hybrid tracer the day before scheduled radical prostatectomy for sentinel lymph node labelling in prostate cancer patients

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with bioptic proven carcinoma of the prostate and with MRI and/or fluorescence imaging guided sentinel lymphadenectomy during radical prostatectomy

Exclusion criteria

Exclusion criteria: patients unable to consent

Design outcomes

Primary

Measure	Time frame
pre-, intra- and post-operative description of patient individual lymphatic drainage of the prostate via pelvic MRI and/or fluorescence imaging	—

Secondary

Measure	Time frame
evaluation of patient individual costs and benefits of image-guided sentinel lymphadenectomy during radical prostatectomy	—

Countries

Germany

Contacts

Public ContactAlexander Winter

Universitätsklinik für Urologie, Klinikum Oldenburg

urologie@klinikum-oldenburg.de+494414032302

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026